基于Ugi反应制备海藻酸衍生物及其载药微胶囊的释药性
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

O636.1

基金项目:

海南省自然科学基金项目(219QN209);海南省高等学校科学研究项目(Hnky2019-36);海南省重点研发项目(ZDYF2019018);国家自然科学基金项目(51963009).


Preparation of Alginate Derivatives via Ugi Reaction and Their Drug-loaded Microcapsules for Drug Delivery
Author:
Affiliation:

Fund Project:

Natural Science Foundation of Hainan Province (219QN209); Scientific Research Projects of Hainan Higher Education Institutions (Hnky2019-36); Key Research and Development Project of Hainan Prov-ince (ZDYF2019018); National Natural Science Foundation of China (51963009)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为了降低成本,减少环境污染,在前人探究Ugi反应改性海藻酸盐的基础上,采用对甲苯磺酰甲基异腈替代环己基异腈和正丙醛替代甲醛的方法,通过Ugi四组分缩合反应制备能够应用于医药制剂领域的海藻酸衍生物(Ugi-Alg)。通过FT-IR和1H NMR对Ugi-Alg的分子结构进行表征,进而分别采用TGA、XRD、荧光光谱(FM)、表面张力(SFT)、TEM、激光粒度和zeta电位分析仪对其性能进行了测试。结果表明,通过Ugi反应成功制备了Ugi-Alg-1和Ugi-Alg-2。疏水侧基的接枝,破坏了原料SA的分子内氢键,使其微晶结构发生改变,热稳定性下降,分子链的灵活性增强。而且Ugi-Alg-1和 Ugi-Alg-2的分子链可通过疏水缔合作用发生自由卷曲,形成水动力学粒径(dH)分别为659.4 nm和534.6 nm,Zeta电位分别为-54.6 mV和-60.8 mV的胶束状聚集体,说明Ugi-Alg-1和 Ugi-Alg-2均具有较好的胶体界面活性。并且Ugi-Alg-1和Ugi-Alg-2的疏水内腔能有效地增溶疏水性的布洛芬,迟滞药物的扩散,使药物释放速率减慢。Ugi-Alg载药微胶囊对布洛芬的释药过程符合 Non-Fickian 扩散机制,说明Ugi-Alg微胶囊溶胀降解与其负载的药物扩散共同控制布洛芬药物的释放速率。

    Abstract:

    To reduce costs and environmental pollution, the alginate derivatives (Ugi-Alg) that can be applied in the field of pharmaceutical formulations were synthesized by the Ugi four-component condensation reaction using the p-tolylsulfonylmethyl isocyanide to replace cyclohexyl isonitrile and n-propionaldehyde to re-place formaldehyde, based on previous explorations of Ugi reaction for the modification of alginate. The molecular structure of Ugi-Alg were characterized by means of FT-IR and 1H NMR, and their properties were determined by TGA, XRD, fluorescence spectrum (FM), surface tension (SFT), TEM, laser particle size and zeta potential analyzers. Experimental results showed that Ugi-Alg-1 and Ugi-Alg-2 were success-fully prepared by Ugi reaction. The grafting of hydrophobic side groups broke the intramolecular hydrogen bonds of the raw SA, changing its microcrystalline structure, decreasing thermal stability, and enhancing the flexibility of the molecular chain. Moreover, the molecular chains of Ugi-Alg-1 and Ugi-Alg-2 could curl freely through hydrophobic association to form the micellar aggregates with the hydrodynamic parti-cle diameters (dH) of 659.4 nm and 534.6 nm, and Zeta potentials of -54.6 mV and-60.8 mV, respectively。These results indicated that both Ugi-Alg-1 and Ugi-Alg-2 has good colloidal interfacial activity. In addi-tion, the hydrophobic lumen of Ugi-Alg-1 and Ugi-Alg-2 can effectively solubilize the hydrophobic ibu-profen, retard the diffusion of the drug, and slow down the drug release rate. The release process of ibu-profen from Ugi-Alg drug-loaded microcapsules conformed to the Non-Fickian diffusion mechanism, in-dicating that the swelling and degradation of Ugi-Alg microcapsules and the diffusion of the loaded drug jointly controlled the release rate of ibuprofen.

    参考文献
    相似文献
    引证文献
引用本文

陈秀琼,冯美西,李正月,颜慧琼,林强.基于Ugi反应制备海藻酸衍生物及其载药微胶囊的释药性[J].精细化工,2021,38(3):

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-08-12
  • 最后修改日期:2020-10-02
  • 录用日期:2020-10-10
  • 在线发布日期: 2021-02-02
  • 出版日期:
文章二维码